Among 16,516 diabetic patients, decreased eGFR and elevated hs-CRP were independently associated with a higher risk of new-onset atrial fibrillation (222 events over 12.6 years).
Cohort (n=16,516)
Does decreased eGFR and elevated hs-CRP increase the risk of new-onset atrial fibrillation in diabetic patients?
In diabetic patients, decreased eGFR and elevated hs-CRP are independently associated with an increased risk of new-onset atrial fibrillation.
Background: Both renal function decline and systemic inflammation may synergistically increase the risk of atrial fibrillation (AF). This study investigates the association between estimated glomerular filtration rate (eGFR) and high-sensitivity C-reactive protein (hs-CRP) levels with the risk of new-onset AF in patients with diabetes mellitus. Methods: We included diabetic patients without AF who participated in physical exams in the Kailuan Study from 2006 to 2010. Participants were categorized into four groups based on baseline eGFR and hs-CRP levels: 1) high eGFR (≥ 60 mL/min/1.73m²) and low hs-CRP (< 3 mg/L) (n=6,915), 2) high eGFR and high hs-CRP (≥ 3 mg/L) (n=3,154), 3) low eGFR (< 60 mL/min/1.73m²) and low hs-CRP (n=4,638), 4) low eGFR and high hs-CRP (n=1,809). We employed multivariable Cox regression analysis to evaluate the relationships between eGFR, hs-CRP, and new-onset AF, adjusting for confounders including smoking status, alcohol consumption, blood pressure, fasting blood glucose (FBG), heart rate, lipid levels, body mass index (BMI), and medication usage. Competing risk analysis was also performed. Results: Among 16,516 patients, 222 developed new-onset AF over a mean follow-up of 12.6 years. After adjusting for confounders, elevated hs-CRP and reduced eGFR were significantly associated with higher risk of new-onset AF compared to the high eGFR/low hs-CRP group. These findings remained consistent after excluding AF cases within the first 2-year. No significant interaction between eGFR and hs-CRP was observed ( P =0.227). Subgroup analysis revealed that the combination of eGFR and hs-CRP had predictive value primarily in males under 60 years of age, individuals with FBG < 9 mmol/L, hypertension, and those not on hypoglycemic medications. Conclusion: In diabetic patients, decreased eGFR and elevated hs-CRP were independently linked to an increased risk of new-onset AF, emphasizing the importance of monitoring these factors for early detection and prevention of AF. Keywords: estimated glomerular filtration rate, high-sensitivity C-reactive protein, atrial fibrillation, diabetes mellitus
Liu et al. (2025) conducted a cohort in Diabetes mellitus (n=16,516). Decreased eGFR and elevated hs-CRP vs. High eGFR (≥ 60 mL/min/1.73m²) and low hs-CRP (< 3 mg/L) was evaluated on New-onset atrial fibrillation. Among 16,516 diabetic patients, decreased eGFR and elevated hs-CRP were independently associated with a higher risk of new-onset atrial fibrillation (222 events over 12.6 years).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: